P63 IHC Lung & Urinary Cancer Test | Lahalak Platform
Precise testing to differentiate between lung and urinary tract cancer types and determine the origin of metastatic tumors, ensuring a clear diagnosis that guides the medical team toward the most appropriate treatment plan.
Scientific name: Immunohistochemistry (IHC) for P63
Immunohistochemical assay for p63 (a member of the p53 protein family) aims to detect this nuclear transcription factor expressed in basal cells and the underlying layers of stratified squamous epithelium, as well as in myoepithelial cells of the breast and prostate, and transitional epithelial cells of the bladder. It is used as a highly specific...
Service type
Laboratory test (Tissue)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Detailed analysis to detect nuclear expression of the transcription factor P63 in tissue samples
- Consult a pathologist to interpret the results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample is a tissue sample (biopsy).
- The tissue sample must be immediately preserved in 10% formalin.
- This analysis is routinely requested in the classification of non-small cell lung tumors (NSCLC), usually with TTF-1 and Napsin A to differentiate between glandular and squamous.
- In prostate biopsies, it is usually requested with the AMACR label (P504S) in a double package (P63-/AMACR+ is typical for adenocarcinoma).
Medical services you might also like
